News
HAE
62.51
+0.35%
0.22
Haemonetics (NYSE:HAE) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Simply Wall St · 1d ago
Interesting HAE Put And Call Options For May 16th
NASDAQ · 3d ago
Weekly Report: what happened at HAE last week (0203-0207)?
Weekly Report · 4d ago
Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect
Barchart · 5d ago
Haemonetics Earnings Call: Growth Amid Challenges
TipRanks · 6d ago
Haemonetics Price Target Cut to $115.00/Share From $120.00 by Raymond James
Dow Jones · 02/07 17:11
Haemonetics Is Maintained at Market Outperform by JMP Securities
Dow Jones · 02/07 17:06
Haemonetics Price Target Cut to $100.00/Share From $125.00 by JMP Securities
Dow Jones · 02/07 17:06
Raymond James Reiterates Strong Buy on Haemonetics, Lowers Price Target to $115
Benzinga · 02/07 17:00
JMP Securities Maintains Market Outperform on Haemonetics, Lowers Price Target to $100
Benzinga · 02/07 16:57
HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket
NASDAQ · 02/07 14:14
Haemonetics downgraded at Bank of America on revised FY25 outlook
Seeking Alpha · 02/07 14:03
Haemonetics Price Target Cut to $108.00/Share From $112.00 by Needham
Dow Jones · 02/07 13:50
Haemonetics Is Maintained at Buy by Needham
Dow Jones · 02/07 13:50
Needham Maintains Buy on Haemonetics, Lowers Price Target to $108
Benzinga · 02/07 13:39
Haemonetics price target lowered to $115 from $120 at Raymond James
TipRanks · 02/07 13:30
Haemonetics price target lowered to $90 from $115 at Mizuho
TipRanks · 02/07 13:07
Haemonetics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga · 02/07 13:00
Haemonetics Price Target Cut to $95.00/Share From $108.00 by Barrington Research
Dow Jones · 02/07 12:55
Haemonetics Is Maintained at Outperform by Barrington Research
Dow Jones · 02/07 12:55
More
Webull provides a variety of real-time HAE stock news. You can receive the latest news about Haemonetics Corp Mass through multiple platforms. This information may help you make smarter investment decisions.
About HAE
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.